⌘K

Login Start Free

Home/Filings/4/0001209191-22-019311

4//SEC Filing

Sabbagh Marwan 4

Accession 0001209191-22-019311

CIK 0001662774other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 6:33 PM ET

Size

5.3 KB

Accession

0001209191-22-019311

Insider Transaction Report

Form 4

Period: 2022-03-14

Cortexyme, Inc.CRTX

Director

Transactions

Award
Stock Option (right to buy)
2022-03-14+22,058→ 22,058 total
Exercise: $4.79Exp: 2032-03-13→ Common Stock (22,058 underlying)

Footnotes (1)

[F1]The shares subject to the option shall vest in equal annual installments over the three-year period following the grant date of March 14, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cortexyme, Inc.

CIK 0001662774

Entity typeother

Related Parties

1

filerCIK 0001917672

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 6:33 PM ET
Size: 5.3 KB

View on SEC.gov